A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)
Phase 4
Completed
- Conditions
- Contraception
- Interventions
- Combination Product: Paragard® T380A Intrauterine Copper Contraceptive with New Inserter
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- CooperSurgical Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT05309694
- Locations
- 🇺🇸
Austin Area Ob-Gyn & Fertility, Austin, Texas, United States
🇺🇸Hilltop Obstetrics & Gynecology, Franklin, Ohio, United States
🇺🇸Downtown Women's Healthcare, Denver, Colorado, United States
Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System
Phase 4
Completed
- Conditions
- Menorrhagia
- Interventions
- Device: Extended treatment regimen using Her Option Cryotherapy
- First Posted Date
- 2004-10-21
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- CooperSurgical Inc.
- Target Recruit Count
- 82
- Registration Number
- NCT00094536
- Locations
- 🇺🇸
Center for Endometrial Ablation, Charlotte, North Carolina, United States
🇺🇸Institute for Women's Health & Body, Wellington, Florida, United States
🇺🇸Jose Manjon, M.D. (Private practice), Camp Hill, Pennsylvania, United States